These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20851824)

  • 1. Pre-clinical detection of amiodarone-induced acute fibrosing alveolitis by intra-thoracic impedance monitor of an implantable cardioverter-defibrillator.
    Hsieh YC; Huang JL; Chin CS; Lin TC; Liao YC; Ting CT; Wu TJ
    Europace; 2011 Jan; 13(1):137-9. PubMed ID: 20851824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
    Bokhari F; Newman D; Greene M; Korley V; Mangat I; Dorian P
    Circulation; 2004 Jul; 110(2):112-6. PubMed ID: 15238454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure.
    Singh SN; Poole J; Anderson J; Hellkamp AS; Karasik P; Mark DB; Lee KL; Bardy GH;
    Am Heart J; 2006 Nov; 152(5):974.e7-11. PubMed ID: 17070171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
    Bardy GH; Lee KL; Mark DB; Poole JE; Packer DL; Boineau R; Domanski M; Troutman C; Anderson J; Johnson G; McNulty SE; Clapp-Channing N; Davidson-Ray LD; Fraulo ES; Fishbein DP; Luceri RM; Ip JH;
    N Engl J Med; 2005 Jan; 352(3):225-37. PubMed ID: 15659722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of amiodarone to postoperative complications of transthoracic implantation of automatic implantable cardioverter defibrillators.
    Calkins H; Bahu M; Shyr Y; Schork A; Bolling S; Kou W; Kirsch M; Morady F
    Panminerva Med; 1996 Jun; 38(2):89-97. PubMed ID: 8979740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irregular ventricular tachycardia underdetected by implantable cardioverter defibrillator device.
    Manolis AG; Kourouklis S; Chatzis D; Kouvelas K; Kyriakides Z
    Cardiol J; 2008; 15(3):281-3. PubMed ID: 18651422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death.
    Lau EW; Griffith MJ; Pathmanathan RK; Ng GA; Clune MM; Cooper J; Marshall HJ; Forsey PR; Stafford PJ; Gray RG; Skehan JD; Garratt CJ
    Europace; 2004 Jul; 6(4):257-66. PubMed ID: 15172648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter by Dardas and Aaronson regarding article, "Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial".
    Dardas TF; Aaronson KD
    Circulation; 2010 Oct; 122(15):e486; author reply e487. PubMed ID: 20937985
    [No Abstract]   [Full Text] [Related]  

  • 9. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
    Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS
    Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone].
    Della Bella P
    Ital Heart J Suppl; 2000 Aug; 1(8):1070-1. PubMed ID: 10993020
    [No Abstract]   [Full Text] [Related]  

  • 11. Potential impact of antiarrhythmic drugs versus implantable defibrillators on the management of ventricular arrhythmias: the Midlands trial of empirical amiodarone versus electrophysiologically guided intervention and cardioverter implant registry data.
    Pathmanathan RK; Lau EW; Cooper J; Newton L; Skehan JD; Garratt CJ; Griffith MJ
    Heart; 1998 Jul; 80(1):68-70. PubMed ID: 9764063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrosing alveolitis associated with amiodarone.
    Butland RJ; Millard FJ
    Eur J Respir Dis; 1984 Nov; 65(8):616-9. PubMed ID: 6519217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed detection of stable ventricular tachycardia in a dual-chamber implantable cardioverter defibrillator: what is the mechanism?
    Strohmer B; Schernthaner C; Pichler M
    J Cardiovasc Electrophysiol; 2004 Feb; 15(2):244-6. PubMed ID: 15028059
    [No Abstract]   [Full Text] [Related]  

  • 14. [79-year-old patient with dyspnoea and blue skin colour].
    Michalski T
    Dtsch Med Wochenschr; 2011 Sep; 136(37):1845-6. PubMed ID: 21898276
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence of appropriate cardioverter-defibrillator shocks in 1038 consecutive patients with implantable cardioverter-defibrillators.
    Kruger A; Aronow WS; Lai H; Desai H; Singla A; Frishman WH; Cohen M; Sorbera C
    Am J Ther; 2009; 16(4):323-5. PubMed ID: 19617719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable defibrillators and/or amiodarone: alternatives or complementary therapies.
    Dorian P; Newman D; Greene M
    Int J Clin Pract; 1998 Sep; 52(6):425-8. PubMed ID: 9894382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High defibrillation threshold at cardioverter defibrillator implantation under amiodarone treatment: favorable effects of D, L-sotalol.
    Boriani G; Biffi M; Frabetti L; Maraschi M; Branzi A
    Heart Lung; 2000; 29(6):412-6. PubMed ID: 11080321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter regarding article by Bokhari et al, "Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS)".
    Boriani G; Biffi M; Martignani C
    Circulation; 2005 Jan; 111(3):e26; author reply e26. PubMed ID: 15668348
    [No Abstract]   [Full Text] [Related]  

  • 19. [A hypertensive patient with atrial fibrillation has increasing dyspnea. Cardiac or pulmonary etiology?].
    Stiefelhagen P
    MMW Fortschr Med; 2009 Mar; 151(10):20. PubMed ID: 19472661
    [No Abstract]   [Full Text] [Related]  

  • 20. Amiodarone versus implantable cardioverter defibrillator for asymptomatic nonsustained ventricular tachycardia in nonischemic dilated cardiomyopathy.
    Cawley PJ; Al-Khatib SM
    Am Heart J; 2004 May; 147(5):790-1. PubMed ID: 15131532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.